The Technical AnalystExchange: CPH Sector: Basic Materials Industry: Specialty Chemicals
Chr. Hansen Holding A/S Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.61% DKK549.60
America/New_York / 30 jan 2024 @ 10:59
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 72 328 mill |
| EPS: | 13.00 |
| P/E: | 42.28 |
| Earnings Date: | Jan 09, 2024 |
| SharesOutstanding: | 131.60 mill |
| Avg Daily Volume: | 0.144 mill |
| RATING 2024-01-30 |
|---|
| S+ |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Strong Buy | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 2.21x |
| Company: PE 42.28 | sector: PE 19.09 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.30x |
| Company: PE 42.28 | industry: PE 32.48 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
DKK 539.76 - 559.45 ( +/- 1.79%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | DKK549.60 (-0.61% ) |
| Volume | 0.408 mill |
| Avg. Vol. | 0.144 mill |
| % of Avg. Vol | 283.24 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For CHR.CO
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
CHR.CO
Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company operates through Food Cultures & Enzymes, and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry. The Health & Nutrition segment produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. It has a strategic collaboration with UPL Ltd. to develop and commercialize microbial-based bio solutions for sustainable agriculture. The company was founded in 1843 and is headquartered in Hørsholm, Denmark.